ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1

Historical Holders from Q3 2023 to Q3 2025

Type / Class
Debt / NOTE 1.000% 9/1
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
352,271,743
Holdings value
$579,144,349
% of all portfolios
0%
Number of holders
43
Number of buys
17
Number of sells
-51
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1

Period Principal Value Change Price Investors
2025 Q3 352,271,743 $579,144,349 -$747,537,213 $1.64 43
2025 Q2 981,078,530 $1,277,359,156 -$13,039,270 $1.3 70
2025 Q1 969,592,530 $1,118,503,734 +$88,986,381 $1.15 69
2024 Q4 922,607,020 $983,794,436 +$11,008,622 $1.07 67
2024 Q3 904,121,020 $1,058,866,946 -$27,889,010 $1.17 58
2024 Q2 905,137,980 $978,913,598 -$105,053,955 $1.08 65
2024 Q1 1,012,540,800 $955,060,150 +$37,637,775 $0.9406 69
2023 Q4 979,138,050 $970,383,077 +$19,195,483 $0.9875 67
2023 Q3 976,407,604 $910,151,140 +$910,150,772 $0.9275 55